What is the prevalence of Birt-Hogg-Dubé syndrome?

TL;DR: Birt-Hogg-Dubé syndrome is a rare genetic disorder with an estimated prevalence of 1 in 200,000, though this is likely an underestimate due to significant underdiagnosis and clinical variability. The condition typically presents in adulthood, usually between the ages of 20 and 50, and affects males and females equally without known geographic or ethnic predilection.

What is the estimated prevalence and rarity of Birt-Hogg-Dubé syndrome?

Birt-Hogg-Dubé syndrome (BHD) is classified as a rare disease. While exact global figures are difficult to ascertain, the estimated prevalence is approximately 1 in 200,000 individuals, according to data from Orphanet and the NIH Genetic and Rare Diseases Information Center (GARD). Because the clinical presentation of Birt-Hogg-Dubé syndrome is highly variable—ranging from asymptomatic skin lesions to life-threatening spontaneous pneumothorax or renal cell carcinoma—many individuals remain undiagnosed throughout their lives. Consequently, the true prevalence is likely higher than currently documented in clinical literature.

Does Birt-Hogg-Dubé syndrome affect different groups differently?

Research indicates that Birt-Hogg-Dubé syndrome affects males and females with equal frequency, as it is an autosomal dominant condition caused by mutations in the FLCN gene. There is no evidence suggesting that Birt-Hogg-Dubé syndrome disproportionately impacts specific ethnic groups or geographic regions. Regarding age of onset, the condition is primarily diagnosed in adults. While the genetic mutation is present from birth, the hallmark manifestations of Birt-Hogg-Dubé syndrome, such as skin fibrofolliculomas, pulmonary cysts, and renal tumors, typically do not become clinically apparent until the third to fifth decade of life.

Why is accurate data on Birt-Hogg-Dubé syndrome difficult to obtain?

Several factors contribute to the scarcity of precise epidemiological data for Birt-Hogg-Dubé syndrome:

• Variable Expressivity: Family members carrying the same FLCN mutation may exhibit vastly different symptoms, leading some to go entirely undetected.


• Misdiagnosis: Skin findings associated with Birt-Hogg-Dubé syndrome are often misidentified as common acne or other dermatological conditions, while renal findings may be treated as sporadic cancer.


• Under-reporting: Many individuals with mild forms of Birt-Hogg-Dubé syndrome may never seek medical attention for their symptoms, resulting in an "under-ascertainment" bias in medical registries.

How does the DiseaseMaps.org community reflect the reality of Birt-Hogg-Dubé syndrome?

While clinical databases provide statistical estimates, the DiseaseMaps.org community offers a valuable real-world perspective on Birt-Hogg-Dubé syndrome. Currently, 114 people with Birt-Hogg-Dubé syndrome have joined the community and shared their experiences. This collective data helps bridge the gap between theoretical prevalence and the lived experience of patients, highlighting the diagnostic journey and the common challenges faced by those managing Birt-Hogg-Dubé syndrome globally.

Next steps

• Consult a geneticist or a nephrologist if you have a family history of spontaneous pneumothorax or early-onset renal tumors.


• Request genetic testing for the FLCN gene if Birt-Hogg-Dubé syndrome is suspected based on your clinical symptoms.


• Connect with the 114 members on DiseaseMaps.org to share experiences and find support regarding surveillance protocols.


• Ensure you are receiving regular kidney imaging (MRI or CT) as recommended by your specialist to monitor for renal manifestations of Birt-Hogg-Dubé syndrome.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician regarding any medical condition.

References

• Orphanet: Birt-Hogg-Dubé syndrome (ORPHA:125)


• NIH Genetic and Rare Diseases Information Center (GARD): Birt-Hogg-Dubé syndrome


• OMIM (Online Mendelian Inheritance in Man): Birt-Hogg-Dubé syndrome (#135150)


• The BHD Foundation: Clinical resources and patient support data